drugset / Trial / NCT02752646

Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%

NCT02752646

Completed 200 enrolled MDbackline, LLC Alcon Research · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will examine the tolerability and toxicity of topically applied Nepafenac 0.3% vs ketorolac 0.5% among patients undergoing cataract surgery.

Timeline

Start
2016-04
Primary completion
2017-03-01
Completion
2017-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 0.5 % Topical
Comparator Nepafenac Other / unclassified 0.3 % Topical

Indications